drugset / Trial / NCT00444340
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is an extension trial of 0881A3-312-EU and is designed to provide information on the safety and efficacy of etanercept in patients with ankylosing spondylitis for up to 3 additional years.
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | — | — |